China, Sept. 15 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Effect of Yangxin Dingji Capsules Combined with Dronedarone on the Prognosis of Patients Undergoing Radiofrequency Catheter Ablation for Atrial Fibrillation'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600132434
Registration Time: 2026/09/14
Type: Interventional study
Primary Sponsor: The second hospital of hebei medical university
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=323536
Published by HT Digital Content Services with permission from Health Daily Digest....